Bulletin
Investor Alert

Company Close Updates

May 11, 2021, 4:31 p.m. EDT

Moderna Inc. stock rises Tuesday, outperforms market

MarketWatch Automation

Shares of Moderna Inc. MRNA inched 0.28% higher to $158.99 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to 13,389.43 and Dow Jones Industrial Average DJIA falling 1.36% to 34,269.16. Moderna Inc. closed $30.27 below its 52-week high ($189.26), which the company reached on February 8th.

The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV fell 1.14% to $114.89, Amgen Inc. AMGN fell 0.13% to $252.30, and AstraZeneca PLC ADR AZN fell 0.51% to $54.10. Trading volume (8.1 M) remained 1.9 million below its 50-day average volume of 10.0 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.